Targeting TNF/TNFR superfamilies in immune-mediated inflammatory diseases

PK Veerasubramanian, TA Wynn, J Quan… - Journal of Experimental …, 2024 - rupress.org
Dysregulated signaling from TNF and TNFR proteins is implicated in several immune-
mediated inflammatory diseases (IMIDs). This review centers around seven IMIDs …

The rise of precision cellular therapies

MF Konig - Nature Reviews Rheumatology, 2024 - nature.com
The rise of precision cellular therapies | Nature Reviews Rheumatology Skip to main content
Thank you for visiting nature.com. You are using a browser version with limited support for …

[HTML][HTML] Disappearance of antiphospholipid antibodies after anti-CD19 chimeric antigen receptor T-cell therapy of B-cell lymphoma in a patient with systemic lupus …

E Friedberg, P Wohlfarth, AI Schiefer, C Skrabs… - Journal of Thrombosis …, 2025 - Elsevier
Antiphospholipid syndrome is an autoimmune disorder characterized by the development of
spontaneous venous, arterial, or microvascular thrombosis and/or pregnancy-related …

Acute kidney injury following CAR-T cell therapy: a nephrologist's perspective

M Kanbay, B Mizrak, EN Alper, S Copur… - Clinical Kidney …, 2025 - academic.oup.com
Chimeric antigen receptor T (CAR-T) cell therapy, an emerging personalized
immunotherapy for various haematologic malignancies, autoimmune diseases and other …

New and emerging therapies for systemic lupus erythematosus

E Papachristodoulou, VC Kyttaris - Clinical Immunology, 2024 - Elsevier
Abstract Systemic Lupus Erythematosus (SLE) and lupus nephritis treatment is still based on
non-specific immune suppression despite the first biological therapy for the disease having …

Highlighting individual patient data related to chimeric antigen receptor T-cell therapy in refractory autoimmune rheumatic diseases

ML Larsen, A Voss… - Scandinavian Journal …, 2025 - Taylor & Francis
Evidence for chimeric antigen receptor T-cell (CAR-T) treatment in systemic autoimmune
rheumatic diseases (ARDs) is limited, often based on short-term clinical investigations or …

Highlight of 2023: CAR T cells driving precision therapy for autoimmune disease.

AYS Lee, JH Reed - Immunology and Cell Biology, 2024 - europepmc.org
CAR T cell therapy is showing remarkable results in autoimmune disease with treatment-
refractory patients showing durable drug-free remission. Here, we highlight five key papers …